‘Compelling’ mid-stage data for Vertex’ CF drugs

20th July 2017 Uncategorised 0

Vertex Pharmaceuticals has unveiled “compelling data” from Phase I and Phase II studies assessing three experimental triple combination regimens for patients with certain forms of cystic fibrosis (CF).

More: ‘Compelling’ mid-stage data for Vertex’ CF drugs
Source: News